Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes

This trial is testing whether continuous glucose monitoring (CGM) — a small sensor worn on the body that tracks blood sugar levels around the clock — can help Chinese American immigrants with type 2 diabetes better manage their blood sugar compared to standard care. **You may be eligible if...** - You are a Chinese American who immigrated to the US as a first-generation immigrant - You are 40 years or older - You have been diagnosed with type 2 diabetes and your HbA1c (long-term blood sugar measure) is above 7.5% - You have never used a continuous glucose monitor before - You own a smartphone - You currently live in the US **You may NOT be eligible if...** - You have been diagnosed with dementia or a learning disability - You are not fluent in either English or Chinese - You are unable to travel to study visits due to health reasons - You are currently on dialysis or critically ill - You do not have internet access - You are pregnant or planning to become pregnant during the study Talk to your doctor to see if this trial is right for you.